Target intelligence / Profile preview

Pathogenic anaerobic bacterium

Molecular classification
Other
01

Overview

Pathogenic anaerobic bacteria are a broadly defined group of bacteria capable of causing human disease in low-oxygen or oxygen-free environments. These include both Gram-negative (e.g., Bacteroides, Fusobacterium, Prevotella) and Gram-positive (e.g., Clostridium, Peptostreptococcus, Actinomyces) genera. They are normal constituents of human mucosal microbiota but can cause serious infections—often polymicrobial—when they invade sterile tissues, typically after trauma, surgery, or disruption of anatomic barriers. Infections by these bacteria are characterized by abscesses, tissue necrosis, and sometimes gas formation; some species produce potent toxins contributing to diseases like botulism, tetanus, and colitis. Treatment strategies target broad classes of anaerobes using drugs such as metronidazole, beta-lactams, and carbapenems, but increasing antimicrobial resistance is a growing concern, especially among Bacteroides. Because this is not a single molecular entity but a broad pathogen category, it is not a canonical molecular drug target.

Other names
Anaerobic pathogenic bacteriaAnaerobic pathogensAnaerobic infection-causing bacteriaObligate anaerobic pathogens
02

Mechanism of action

Disruption of DNA synthesis (e.g., metronidazole generates radical species under anaerobic conditions); Inhibition of cell wall synthesis (e.g., beta-lactams, carbapenems); Inhibition of protein synthesis (e.g., clindamycin, macrolides, chloramphenicol, tetracyclines); Targeting specific metabolic enzymes (e.g., PFOR inhibition by amixicile)

03

Biological functions

Pathogenicity (tissue invasion, toxin production)Immune evasionFermentation and anaerobic metabolismFormation of abscesses and biofilms
04

Disease associations

Infection (polymicrobial or mixed; endogenous and exogenous)Abscess formationNecrotizing soft tissue infectionPseudomembranous colitisPeriodontitisAspiration pneumoniaBrain abscessPeritonitisSepsis
05

Safety considerations

Antimicrobial resistance (especially Bacteroides species)Disruption of normal anaerobic flora (may predispose to opportunistic infections or C. difficile overgrowth)Potential for toxin-mediated disease (e.g., botulism, tetanus)Empiric therapy may select for resistant organisms
06

Interacting drugs

Metronidazole

8 more in the full profile.

07

Biomarkers

Anaerobic culture from normally sterile sitesDetection of organism-specific DNA by PCRGas production in infected tissue (clinical radiology/CT)Foul odor or presence of necrotic tissueMixed Gram stain with Gram-negative and Gram-positive morphology

Beyond the preview

Go deeper on Pathogenic anaerobic bacterium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic anaerobic bacterium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call